KLK3 and benign prostatic hyperplasia: Additionally, with a focus on the AA patient subset, we evaluated the performance of FLNA as compared to PSA in classifying 139 AA men with PCa from 25 men with BPH who had more than one negative biopsy (Table 3(B)).